Search Press releases Keywords From To 22 Oct 2020 UCB’s anti-epileptic drug VIMPAT[®] (lacosamide) receives EU CHMP positive opinion for primary generalised tonic-clonic seizures Read More 16 Oct 2020 UCB FURTHER INVESTS IN UK OPERATIONS WITH AGREEMENT TO ACQUIRE A NEW LEADING-EDGE CAMPUS Read More 9 Oct 2020 Disposals of own shares Read More 2 Oct 2020 Disposals of own shares Read More 2 Oct 2020 Changes in UCB's Board of Directors Read More 25 Sep 2020 Disposals of own shares Read More Pagination First page Previous page Previous … Page 55 Page 56 Page 57 Page 58 Current page 59 Page 60 Page 61 Page 62 Page 63 … Page 59 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
